Glofitamab
Refractory Primary Mediastinal Large B-Cell Cell Lymphoma
The Lymphoma Academic Research OrganisationPhase 2
—
Rating in progress
Glofitamab in Refractory Primary Mediastinal Large B-Cell Cell Lymphoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant